Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New liposomal gel may plump aging skin without surgery

NCT ID NCT06997380

Symptom relief Sponsor: Biovico Sp. z o.o. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested an injectable gel made of hyaluronic acid and lecithin in 36 women with thin, dry, and sagging facial skin. The goal was to see if the gel safely improves skin thickness and appearance. Participants received three injections over several visits, and skin changes were measured with ultrasound and imaging.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hyaluronic acid with lecithin liposomes
What this could lead to
If it works, this could offer a non-surgical option to improve facial skin thickness and reduce sagging.
What could go wrong
This is a small, early-stage trial with only 36 participants. Results may not apply to all skin types or ages, and long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

May 2025

Finished

Nov 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Female sex; 2. Age over 18 years; 3. Caucasian race; 4. Thin, dry, and sagging facial skin; 5. Signing an informed consent form; 6. Commitment to refrain from undergoing facial therapies that may affect skin condition; 7. Negative pregnancy test result and commitment to use a contraceptve method; Exclusion Criteria: 1. Scars, birthmarks, or tattoos on the face that could interfere with the assessment of skin condition; 2. Presence of open wounds, ulcers, active infections, or other significant skin damage at the planned injection site; 3. Receipt of intradermal facial injections with native hyaluronic acid, platelet-rich plasma, or other injectable therapies within 6 months prior to study initiation; 4. Receipt of intradermal facial injections with slowly absorbable or non-absorbable filler products within 12 months prior to study initiation; 5. Known hypersensitivity to any component of the investigational product; 6. Dermatitis or dermatological disease of inflammatory and/or infectious nature at the planned injection site; 7. History of cancer, autoimmune disease, or immunodeficiency; 8. Use of medications affecting blood coagulation; 9. Use of topical antihistamines, corticosteroids, or retinoids on the face within 4 weeks prior to the study; 10. Pregnancy or breastfeeding; 11. Participation or planned participation in other clinical trials;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial skin laxity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Facial skin laxity Facial wrinkles Skin aging Skin wrinkling

Contacts and locations

Locations

  • Dr Agnieszka Sirocka - Medycyna Estetyczna

    Kowale, 80-180, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.